OverviewChartNewsTraderScreen

BVT Knock-Out PGR/  DE000VM65563  /

EUWAX
6/21/2024  9:44:23 PM Chg.-0.12 Bid9:59:50 PM Ask9:59:50 PM Underlying Strike price Expiration date Option type
7.18EUR -1.64% -
Bid Size: -		 -
Ask Size: -		 Progressive Corporat... 133.83 USD 12/31/2078 Call
GlobeNewswire 6/21 argenx Announces FDA Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropat...
GlobeNewswire 6/21 Description of the Share Repurchase Program Authorised by the Ordinary General Meeting of 20 June 20...
GlobeNewswire 6/21 Results of the votes of the Combined Shareholders’ General Meeting of June 20, 2024  
GlobeNewswire 6/21 XPPen Joins the RSA Schools Art Award 2024, Celebrating the Wonder of Art with the Young Generation
GlobeNewswire 6/21 Great Pacific Gold Announces New High-Grade Assays at Comet Discovery Including 4m at 22.3 g/t Gold
GlobeNewswire 6/21 Landmark Nature Medicine Study Reports Promising New Treatment Reduces Suffering in Sanfilippo syndr...
GlobeNewswire 6/21 Arvinas Announces Presentations for Two of its PROTAC® Investigational Programs Targeting BCL6 and L...
GlobeNewswire 6/21 Ocugen Announces Data and Safety Monitoring Board Approves Enrollment in High Dose Cohort 3 in GARDi...
GlobeNewswire 6/19 Opthea A$55.0m (US$36.9m¹) Retail Entitlement Offer Opens
GlobeNewswire 6/18 Afamelanotide in fair-skinned Parkinson’s patients
GlobeNewswire 6/14 Progressive Reports May 2024 Results
GlobeNewswire 6/13 Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Progr...
GlobeNewswire 6/12 Ultragenyx Announces Plans to File for Accelerated Approval of UX111 for the Treatment of Sanfilippo...
GlobeNewswire 6/12 Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japa...
GlobeNewswire 6/11 Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...
GlobeNewswire 6/11 Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b...
GlobeNewswire 6/11 FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for Treatment of Multiple Sclero...
GlobeNewswire 6/10 LifeWallet’s Proprietary Data System is Instrumental in Class Certification Against USAA Property an...
GlobeNewswire 6/10 SYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in...
TeleTrader 6/9 EP updated results, EPP with 189 seats
TeleTrader 6/9 EPP's Weber claims party victory in EP election
GlobeNewswire 6/7 TG Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire 6/7 Boehringer Ingelheim’s survodutide shows breakthrough improvement in liver fibrosis with no worsenin...
GlobeNewswire 6/6 Tiziana Life Sciences Announces Six-Month Qualitative Improvement in Neuroimaging in 80% of Multiple...
GlobeNewswire 6/6 4DMT Presents Positive Interim Data from Phase 1/2 AEROW Clinical Trial of Aerosolized 4D-710 for Mo...